Twenty Twenty Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Twenty Twenty Therapeutics General Information

Description

Developer of ophthalmic devices designed to support modern ophthalmology practice globally. The company is focused on harnessing the convergence of AI, microelectronics, and scalable digital technologies with diagnostic and preventative eye care, enabling healthcare professionals to treat eye patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 259 East Grand Avenue
  • South San Francisco, CA 94080
  • United States
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Services
Corporate Office
  • 259 East Grand Avenue
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Twenty Twenty Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Joint Venture 14-Aug-2020 Completed Generating Revenue
To view Twenty Twenty Therapeutics’s complete valuation and funding history, request access »

Twenty Twenty Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Santen Pharmaceutical Corporation Majority
Verily Health PE-Backed Company Majority
Daybreak Labs Accelerator/Incubator
To view Twenty Twenty Therapeutics’s complete investors history, request access »

Twenty Twenty Therapeutics FAQs

  • When was Twenty Twenty Therapeutics founded?

    Twenty Twenty Therapeutics was founded in 2020.

  • Where is Twenty Twenty Therapeutics headquartered?

    Twenty Twenty Therapeutics is headquartered in South San Francisco, CA.

  • What industry is Twenty Twenty Therapeutics in?

    Twenty Twenty Therapeutics’s primary industry is Diagnostic Equipment.

  • Is Twenty Twenty Therapeutics a private or public company?

    Twenty Twenty Therapeutics is a Private company.

  • What is Twenty Twenty Therapeutics’s current revenue?

    The current revenue for Twenty Twenty Therapeutics is .

  • Who are Twenty Twenty Therapeutics’s investors?

    Santen Pharmaceutical, Verily Health, and Daybreak Labs have invested in Twenty Twenty Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process